Bipolar disorder patients' attitudes to and knowledge of their illness: a retrospective study

1993 ◽  
Vol 10 (2) ◽  
pp. 71-75 ◽  
Author(s):  
Patrick McKeon ◽  
Fionnuala O'Loughlin
Keyword(s):  
Bipolar Disorder ◽  
Support Group ◽  
Economic Status ◽  
Relevant Literature ◽  
Depressive Illness ◽  
Manic Depressive Illness ◽  
Duration Of Illness ◽  
Illness Knowledge ◽  
Group Meetings ◽  
Knowledge And Attitude

AbstractObjective: To assess the effect of specific psychoeducational sources – support group meetings, lectures and literature – on bipolar disorder patients' knowledge and attitude to their illness. Methods: Eighty bipolar disorder patients attending for a lithium blood test were asked to complete a questionnaire detailing their demographic characteristics, duration of illness, knowledge of manic-depressive illness and their attitude towards their illness and what exposure they had had to relevant support group meetings, lectures and literature on bipolar disorder. Results: The 43 group attenders had a statistically significant higher mean score on the illness and lithium knowledge and the attitude to illness sections of the questionnaire than the 30 patients who did nto attend groups (P<0.001). A multiple regression analysis indicated that, in addition to group attendances, only reading literature contributed significantly to illness knowledge and attitude. Age, sex, duration of illness and socio-economic status did not contribute significantly to these outcome variables. Conclusions: Bipolar disorder patients who attended support group meetings and availed of relevant literature knew more about their illness and lithium therapy and expressed more positive and realistic views about their illness than those who only read literature and attended lectures.

Manic-depressive illness — II: treatment outcome in bipolar disorder subtypes

1992 ◽  
Vol 9 (1) ◽  
pp. 9-12 ◽  
Author(s):  
Patrick McKeon ◽  
Patrick Manley ◽  
Gregory Swanwick
Keyword(s):  
Bipolar Disorder ◽  
Treatment Outcome ◽  
Antidepressant Drugs ◽  
Depressive Illness ◽  
Tricyclic Antidepressant ◽  
Rapid Cycling ◽  
Manic Depressive Illness ◽  
Mood Changes ◽  
Manic Depressive ◽  
Manic Patients

AbstractThe treatment outcome of 100 bipolar disorder patients (B.P.) was examined retrospectively to determine whether bipolar subtypes had a differential prophylactic response to lithium, carbamazepine, neuroleptics and antidepressant drugs when these treatments were given in a predetermined sequence. Sixty-eight per cent of 53 B.P.-I patients with a mania-depression-normothymic-interval (M.D.I.) sequence of mood changes had a good response to lithium, and all but one of the remainder responded with the addition of carbamazepine or an antidepressant. While only 17% of 12 unipolar manic patients achieved prophylaxis with lithium and a further 17% when carbamazepine was added, the other 66% remained normothymic when a neuroleptic was prescribed with lithium. Of the seven rapid cycling patients where depression preceded mania, 28% had a good prophylactic effect with lithium, a further 28% when a tricyclic antidepressant was added and 14% with lithium and carbamazepine. None of the 18 rapid cycling M.D.I. group had a good response to lithium, but 39% stabilised when carbamazepine was added to lithium. Twenty-eight per cent of this group failed completely to respond to any of the treatments used. Neuroleptics increased the severity and duration of depressive phases for all subtypes except the unipolar mania group.

Manic Mood Disorders

2010 ◽  
Author(s):  
Max Fink MD
Keyword(s):  
Bipolar Disorder ◽  
Severity Of Illness ◽  
Bipolar Disorders ◽  
Manic Episode ◽  
Depressive Illness ◽  
Manic Depressive Illness ◽  
Sleep Difficulty ◽  
Manic Depressive ◽  
Loss Of Appetite ◽  
Manic Patients

Patients suffering from mania are overactive, intrusive, excited, and belligerent. They may believe that they have special powers, are related to public figures, and can read the minds of others. They spend money lavishly. Voices on the radio or television are sometimes understood as personal communications. They speak rapidly, with illogical and confused thoughts, move constantly, and write page after page of nonsense. They typically sleep and eat poorly, have little interest in work, friends, or family, and often require restraint or seclusion. Suicide is a perpetual threat. Some manic patients are likable, while others are angry and frightening. Psychosis is a frequent feature. Manic patients believe that their parents are not their real parents, asserting that they have royal blood. They believe that they can predict the future. They know that others are watching or talking about them, and they hear voices when no one is present. Delusional mania requires more intensive treatment and almost always hospital care. In older classifications of psychiatric illnesses, these patients were considered to be suffering from a manic-depressive illness. In modern classification, this term has been discarded and the illness is now conceived as bipolar disorder for patients with manic and depressive features and major depression for those with depressive symptoms only. Bipolar disorders, ranging from mild to severe, are divided into numerous subtypes. The variety of symptoms that admit the diagnosis of bipolar disorder has led to a virtual epidemic of diagnoses of the condition. Many patients so labeled do not exhibit the sleep difficulty, loss of appetite, and loss of weight, or the severity of illness, that were the criteria for manic-depressive illness. In manic-depressive illness, the manic episode persists for hours, days, weeks, or months and interferes with normal living. Once the episode resolves, it may suddenly recur; or manic episodes may alternate with periods of depression, or occur as simultaneous mixed episodes of depression and mania. When the shift in mood from mania to depression takes place within one or a few days, the condition is labeled rapid cycling, a particularly malignant form of the illness. In manic-depressive illness, the manic episode persists for hours, days, weeks, or months and interferes with normal living.

Brain mechanisms in manic depression

1994 ◽  
Vol 40 (2) ◽  
pp. 303-308 ◽  
Author(s):  
B J Carroll
Keyword(s):  
Bipolar Disorder ◽  
Mood Disorders ◽  
Unipolar Depression ◽  
Depressive Illness ◽  
Manic Depression ◽  
Manic Depressive Illness ◽  
Manic Depressive ◽  
Clinical Presentations ◽  
Genetic Mechanisms ◽  
Activity Information

Abstract Manic depressive illness (bipolar disorder) is the mood disorder classically considered to have a strong biological basis. During manic depressive cycles, patients show dramatic fluctuations of mood, energy, activity, information processing, and behaviors. Theories of brain function and mood disorders must deal with the case of bipolar disorder, not simply unipolar depression. Shifts in the nosologic concepts of how manic depression is related to other mood disorders are discussed in this overview, and the renewed adoption of the Kraepelinian "spectrum" concept is recommended. The variable clinical presentations of manic depressive illness are emphasized. New genetic mechanisms that must be considered as candidate factors in relation to this phenotypic heterogeneity are discussed. Finally, the correlation of clinical symptom clusters with brain systems is considered in the context of a three-component model of manic depression.

The Beast in White’s Jungle: Manic-Depressive Illness

2018 ◽  
Author(s):  
Patricia Moran
Keyword(s):  
Bipolar Disorder ◽  
Virginia Woolf ◽  
Family Members ◽  
Depressive Illness ◽  
Manic Depressive Illness ◽  
Manic Depressive ◽  
Key Sites

This chapter discusses White’s illness within the context of medical and subjective accounts of bipolar disorder. It opens with a selective overview of White’s life that highlights the key sites of disruption and signs of illness. It then turns to an overview of manic-depressive illness, followed by a more detailed description of the characteristics of manic, depressive and mixed episodes. It ends with a brief comparison of White’s experiences of illness to those of her contemporary Virginia Woolf. This comparison demonstrates not only the diverse expressions of manic-depressive illness but also the different approaches that the writers themselves as well as family members adopted to cope with it.

Bipolar disorder

2017 ◽  
pp. 233-252 ◽  
Author(s):  
Paul Harrison ◽  
Philip Cowen ◽  
Tom Burns ◽  
Mina Fazel
Keyword(s):  
Bipolar Disorder ◽  
Bipolar Depression ◽  
Unipolar Depression ◽  
Depressive Illness ◽  
Mood Stabilizers ◽  
Manic Depressive Illness ◽  
Bipolar Illness ◽  
Manic Depressive ◽  
Additional Section

‘Bipolar disorder’ provides an account of the clinical and scientific aspects of bipolar disorder (‘manic depressive illness’). Identification of varying degrees of mood elevation is critical to the diagnosis of bipolar disorder to allow its distinction from unipolar depression, and the phenomenology and classification of manic states is described in detail. The range of aetiological factors involved in the development of bipolar illness is covered, from genetics and brain structure to psychology and life events. The efficacy of treatments both psychological and pharmacological in bipolar disorder is assessed, including new approaches with psychoeducation, atypical antipsychotic drugs, and anticonvulsant mood stabilizers. An additional section covers the clinically challenging treatment of bipolar depression. The evidence from clinical trials is then placed in the context of good clinical management of both the acute phases of bipolar illness as well as longer-term maintenance treatment.

The Impact of Mood Stabilizers on Suicide in Bipolar Disorder: A Comparative Analysis

CNS Spectrums ◽  
2000 ◽  
Vol 5 (S1) ◽  
pp. 12-18 ◽  
Author(s):  
Frederick K. Goodwin ◽  
S. Nassir Ghaemi
Keyword(s):  
Bipolar Disorder ◽  
Suicide Risk ◽  
Depressive Illness ◽  
Mood Stabilizers ◽  
Manic Depressive Illness ◽  
Stabilizing Agents ◽  
Manic Depressive ◽  
Suicide Risk Factors ◽  
Serotonergic Function ◽  
The Impact

AbstractWhich mood stabilizers are the most effective in reducing suicide rates in patients with bipolar disorder? This paper reviews the literature and compares the data on two types of mood-stabilizing agents, lithium and anticonvulsants. Compared with the large amount of data on lithium, there is surprising little information available on the effects of anticonvulsants on mortality in manic-depressive illness. Each was also assessed in terms of suicide risk factors such as depression and mixed episodes, rapid cycling, substance abuse, anxiety and panic, and central serotonergic function. Only two studies that provide data demonstrating anticonvulsant efficacy in preventing suicide in bipolar disorder are available, and the data are incomplete at best. Further research in this area should include an emphasis on the outcome of mortality in patients treated with any of the anticonvulsants or with lithium-anticonvulsant combinations.

Factitious Disorder in a Manic Patient: Case Report and Treatment Considerations

1986 ◽  
Vol 15 (4) ◽  
pp. 365-369 ◽  
Author(s):  
Arthur Lazarus
Keyword(s):  
Bipolar Disorder ◽  
Case Report ◽  
Signs And Symptoms ◽  
Physical Symptoms ◽  
Depressive Illness ◽  
Factitious Disorder ◽  
Manic Depressive Illness ◽  
Patient Case ◽  
Manic Depressive ◽  
Treatment Considerations

A case of factitious disorder with physical symptoms is described in a patient with manic-depressive illness. The coexistence of factitious disorder and bipolar disorder has not been previously reported. Clinicians should search for an underlying affective disorder in patients who fabricate signs and symptoms of physical illness, since mania may simulate or contribute to the production of factitious behavior.

From Obsessivity to Bipolarity and Vice Versa. A Literature Review

2016 ◽  
Vol 33 (S1) ◽  
pp. S494-S494
Author(s):  
P. Cano Ruiz ◽  
S. Cañas Fraile ◽  
A. Gómez Peinado ◽  
P. Sanmartin Salinas
Keyword(s):  
Bipolar Disorder ◽  
Depressive Illness ◽  
Bipolar Spectrum ◽  
Manic Depressive Illness ◽  
Bipolar Spectrum Disorders ◽  
Increased Risk ◽  
Spectrum Disorders ◽  
Competing Interest ◽  
Bipolar Patients ◽  
Depressive Episodes

IntroductionThe prevalence of obsessive symptoms in bipolar patients is currently under discussion. Last years, different cases of antidepressant-induced mania and hypomania in patients with OCD have been described.Several authors have reported that patients with OCD and bipolar disorder have more depressive episodes than patients with only OCD.ObjectiveTo know the relationship between OCD and other bipolar spectrum disorders.MethodBibliographical review on comorbidity between obsessive symptoms and bipolarity.ResultsSome longitudinal analysis have shown that patients firstly diagnosed with OCD have an increased risk for subsequent diagnosis of all other conditions, especially for bipolar and schizoaffective disorder, for those whose risk is of up to 13 times higher. The handling of a patient with bipolar disorder and OCD implies some difficulty, because of the main treatment of anxiety disorders, the antidepressants, alters the course of manic-depressive illness, accelerating cycles.ConclusionsOCD is etiologically related to bipolar spectrum disorders and schizophrenia. Therefore, it is necessary to continue the investigation of possible involved genes and approaches for clinical practice.Disclosure of interestThe authors have not supplied their declaration of competing interest.

A REVIEW ON USE OF LITHIUM IN BIPOLAR DISORDER

INDIAN DRUGS ◽  
2013 ◽  
Vol 50 (09) ◽  
pp. 5-17
Author(s):  
D. B Bhavsar ◽  
◽  
U. S Desai ◽  
A. A Phatak ◽  
P. D Chaudhari .
Keyword(s):  
Bipolar Disorder ◽  
Medical Condition ◽  
Dose Range ◽  
Mood Stabilizer ◽  
Manic Episode ◽  
Depressive Illness ◽  
Mood Stabilizers ◽  
Therapeutic Drug ◽  
Manic Depressive Illness ◽  
Toxic Reaction

Bipolar disorder (previously called manic depressive illness) is a medical condition involving changes in the brain function leading to dramatic mood swings. It is characterized by the occurrence of at least one manic or mixed-manic episode, commonly treated with mood stabilizers. Sometimes, antipsychotics and antidepressants are used along with mood stabilizers. Lithium, a very effective mood stabilizer, was the first anti-manic depressant drug approved by the USFDA in the 1970’s. Though the specific biochemical mechanism of its action is unknown, preclinical studies have shown that lithium alters sodium transport in nerve cells and effects a shift toward intraneuronal metabolism of catecholamine. Although lithium is drug of choice in the treatment of bipolar disorder, the safe dose range is relatively narrow, and therapeutic drug monitoring is needed in order to prevent toxic reaction after its oral administration. So, there is scope for the alternative route of administration of lithium, which gives optimum drug levels and produces effects in low dose.

Sign in / Sign up

Export Citation Format

Share Document